When Should Antiplatelet Agents Be Resumed After Successful Endoscopic Hemostasis in Patients with Peptic Ulcer Bleeding

Jung Wook Kim,Hyun Jin Park,Jae-Young Jang,Chi Hyuk Oh,Jae-Jun Shim,Chang Kyun Lee,Young Woon Chang

When Should Antiplatelet Agents Be Resumed After Successful Endoscopic Hemostasis in Patients with Peptic Ulcer Bleeding

2016

Jung Wook Kim
Hyun Jin Park
Jae-Young Jang
Chi Hyuk Oh
Jae-Jun Shim
Chang Kyun Lee
Young Woon Chang

Background During treatment for peptic ulcer bleeding (PUB), it is imperative to determine the effect of antiplatelet agents on recurrent bleeding in order to balance risks and benefits.

Keywords:

Peptic ulcer bleeding
Diabetes mellitus
Medicine
Hemostasis
Gastrointestinal bleeding
Surgery
Internal medicine
Hepatology
Transplant surgery
risks and benefits
in patient
recurrent bleeding
endoscopic hemostasis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations